Literature DB >> 18979018

Protocol for dengue infections in mosquitoes (A. aegypti) and infection phenotype determination.

Suchismita Das1, Lindsey Garver, Jose Ruiz Ramirez, Zhiyong Xi, George Dimopoulos.   

Abstract

The purpose of this procedure is to infect the Aedes mosquito with dengue virus in a laboratory condition and examine the infection level and dynamic of the virus in the mosquito tissues. This protocol is routinely used for studying mosquito-virus interactions, especially for identification of novel host factors that are able to determine vector competence. The entire experiment must be conducted in a BSL2 laboratory. Similar to Plasmodium falciparum infections, proper attire including gloves and lab coat must be worn at all times. After the experiment, all the materials that came in contact with the virus need to be treated with 75% ethanol and bleached before proceeding with normal washing. All other materials need to be autoclaved before discarding them.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18979018      PMCID: PMC2557096          DOI: 10.3791/220

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  21 in total

1.  Dengue virus infection of the Aedes aegypti salivary gland and chemosensory apparatus induces genes that modulate infection and blood-feeding behavior.

Authors:  Shuzhen Sim; José L Ramirez; George Dimopoulos
Journal:  PLoS Pathog       Date:  2012-03-29       Impact factor: 6.823

2.  Wolbachia induces reactive oxygen species (ROS)-dependent activation of the Toll pathway to control dengue virus in the mosquito Aedes aegypti.

Authors:  Xiaoling Pan; Guoli Zhou; Jiahong Wu; Guowu Bian; Peng Lu; Alexander S Raikhel; Zhiyong Xi
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-28       Impact factor: 11.205

3.  An experimental and bioinformatics protocol for RNA-Seq analyses of photoperiodic diapause in the Asian tiger mosquito, Aedes albopictus.

Authors:  Monica F Poelchau; Xin Huang; Allison Goff; Julie Reynolds; Peter Armbruster
Journal:  J Vis Exp       Date:  2014-11-30       Impact factor: 1.355

4.  Human C5a Protein Participates in the Mosquito Immune Response Against Dengue Virus.

Authors:  Berlin Londono-Renteria; Crystal Grippin; Jenny C Cardenas; Andrea Troupin; Tonya M Colpitts
Journal:  J Med Entomol       Date:  2016-02-03       Impact factor: 2.278

5.  Aedes aegypti ML and Niemann-Pick type C family members are agonists of dengue virus infection.

Authors:  Natapong Jupatanakul; Shuzhen Sim; George Dimopoulos
Journal:  Dev Comp Immunol       Date:  2013-10-14       Impact factor: 3.636

6.  Reciprocal tripartite interactions between the Aedes aegypti midgut microbiota, innate immune system and dengue virus influences vector competence.

Authors:  Jose Luis Ramirez; Jayme Souza-Neto; Rolando Torres Cosme; Jose Rovira; Alma Ortiz; Juan M Pascale; George Dimopoulos
Journal:  PLoS Negl Trop Dis       Date:  2012-03-06

7.  Wolbachia induces density-dependent inhibition to dengue virus in mosquito cells.

Authors:  Peng Lu; Guowu Bian; Xiaoling Pan; Zhiyong Xi
Journal:  PLoS Negl Trop Dis       Date:  2012-07-24

8.  Replacing a native Wolbachia with a novel strain results in an increase in endosymbiont load and resistance to dengue virus in a mosquito vector.

Authors:  Guowu Bian; Guoli Zhou; Peng Lu; Zhiyong Xi
Journal:  PLoS Negl Trop Dis       Date:  2013-06-06

9.  Glytube: a conical tube and parafilm M-based method as a simplified device to artificially blood-feed the dengue vector mosquito, Aedes aegypti.

Authors:  André Luis Costa-da-Silva; Flávia Rosa Navarrete; Felipe Scassi Salvador; Maria Karina-Costa; Rafaella Sayuri Ioshino; Diego Soares Azevedo; Desirée Rafaela Rocha; Camila Malta Romano; Margareth Lara Capurro
Journal:  PLoS One       Date:  2013-01-14       Impact factor: 3.240

10.  Inhibition of dengue virus entry into target cells using synthetic antiviral peptides.

Authors:  Mohammed Abdelfatah Alhoot; Alwin Kumar Rathinam; Seok Mui Wang; Rishya Manikam; Shamala Devi Sekaran
Journal:  Int J Med Sci       Date:  2013-04-16       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.